NCT03962686View on ClinicalTrials.gov

Molecular Mechanisms and Carotid Atherosclerosis

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

January 1, 2017

Study Completion Date

January 1, 2018

Conditions
Diabetes Mellitus, Type 2Atherosclerosis of ArteryAtherosclerotic Plaque
Interventions
DRUG

statin Oral Tablet plus PCSK9i

Patients in the third study cohort will receive for statin oral therapy plus 140 mg twice a month PCSK9i therapy via subcutaneous injection before to practice surgical intervention for carotid artery obstruction.

Trial Locations (1)

80138

Raffaele Marfella, Naples

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT03962686 - Molecular Mechanisms and Carotid Atherosclerosis | Biotech Hunter | Biotech Hunter